This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Anges Mg, Inc.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Marvin A. Tanag: Innovator in Tissue Survival Enhancement
Introduction
Marvin A. Tanag is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of tissue survival through his innovative research and inventions. His work focuses on enhancing the survival of organ transplants and skin grafts, which is crucial in medical procedures.
Latest Patents
Marvin A. Tanag holds a patent for a groundbreaking invention titled "Hepatocyte growth factor nucleic acid sequence to enhance musculocutaneous flap survival." This patent relates to the use of growth factors to improve tissue survival. Specifically, it describes methods for enhancing organ transplant, musculocutaneous flap, or skin graft survival by administering a nucleic acid sequence encoding hepatocyte growth factor. He has 1 patent to his name.
Career Highlights
Tanag is associated with Anges MG, Inc., where he continues to work on innovative solutions in the medical field. His research has the potential to significantly impact surgical outcomes and patient recovery.
Collaborations
Throughout his career, Marvin has collaborated with esteemed colleagues, including Tateki Kubo and Kenji Yano. These partnerships have fostered a collaborative environment that enhances the development of innovative medical solutions.
Conclusion
Marvin A. Tanag is a distinguished inventor whose work in enhancing tissue survival is paving the way for advancements in medical procedures. His contributions are vital for improving the success rates of organ transplants and skin grafts.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile